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Rates	 of	 contraceptive	 discontinuation	 are	 high	 worldwide,1 
including	 in	Ghana.2	Although	 long-	acting	reversible	contraceptive	
(LARC)	 methods	 are	 widely	 available	 and	 safe	 for	 most	 women,3 
few	 Ghanaian	 women	 use	 them.4	 We	 aimed	 to	 prospectively	
assess	whether	 discontinuation	 rates	 differed	 among	women	who	
adopted	 a	 LARC	method	versus	 those	who	 adopted	 a	 short-	term	 
hormonal	method.
Between	 June	 1	 and	 August	 31,	 2015,	 we	 recruited	 women	
aged	 18	years	 or	 older	 who	 were	 seeking	 contraception	 at	 three	
family	planning	clinics	 in	Accra,	Ghana.	The	study	was	reviewed	and	











method	 and	 those	 who	 adopted	 a	 short-	term	 hormonal	 method.	
Analysis	was	done	with	Stata	version	13	(StataCorp,	College	Station,	
TX,	 USA).	 Given	 the	 low	 frequency	 of	 discontinuation	 outcomes,	
use	of	inferential	statistics	controlling	for	confounding	variables	was	
not	possible.
Of	 151	 women	 who	 adopted	 a	 LARC	 or	 short-	term	 method,	
87	 (57.6%)	 women	 were	 retained	 in	 the	 study	 at	 9–12	months	
(Table	1).	 The	 9–12	month	 continuation	 rate	 was	 almost	 95%	 in	
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Still using at 
9–12 months
Would use this method again
Agree Neutral Disagree
LARC
Implant 63 40/63	(63.5) 38/40	(95.0) 26/40	(65.0) 14/40	(35.0) 0
IUD 24 16/24	(66.7) 15/16	(93.8) 10/16	(62.5) 4/16	(25.0) 2/16	(12.5)
Combined 87 56/87	(64.4) 53/56	(94.6) 36/56	(64.3) 18/56	(32.1) 2	(3.6)
Short-	term	hormonal
Injection 53 24/53	(45.3) 18/24	(75.0) 16/24	(66.7) 6/24	(25.0) 2/24	(8.3)
Pill 11 7/11	(63.6) 4/7	(57.1) 6/7	(85.7) 1/7	(14.2) 0
Combined 64 31/64	(48.4) 22/31	(71.0) 22/31	(70.1) 7	(22.6) 2	(6.5)
Abbreviations:	LARC,	long-	acting	reversible	contraceptive;	IUD,	intrauterine	device.
aValues	are	given	as	absolute	number	or	number/number	available	(percentage).
Received:	11	November	2017  |  Revised:	28	February	2018  |  Accepted:	1	May	2018  |  First	published	online:	20	May	2018
DOI: 10.1002/ijgo.12520
G y n e c o l o g y
Single- incision laparoscopic abdominal cerclage placement: 
A retrospective study of single- port and robotic single- port 
versus multiport laparoscopy






K E Y W O R D S : 	 Abdominal	cerclage;	Laparoscopy;	Robotic	single	incision	laparoscopic	surgery;	Single	incision	laparoscopic	surgery
